Related Experiment Video
Updated: Jun 13, 2026

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
Published on: July 4, 2018
Cystic fibrosis gene mutations and gastrointestinal diseases
Shahram Bahmanyar1, Anders Ekbom, Johan Askling
1Clinical Epidemiology Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden. Shahram.Bahmanyar@ki.se
Background:
This study examined if CF mutation heterozygosity is associated with diseases of gastrointestinal epithelial barrier function.
Design And Methods:
Swedish registers identified 865 patients with a diagnosis of CF between 1968 and 2003 and matched with 8101 individuals without CF. Gastrointestinal disease risk was examined among 1534 biological parents and 1396 siblings of CF patients, compared with 15,526 parents and 15,542 siblings of individuals without CF.
Results:
First-degree relatives of CF patients were not at lower risk of the gastrointestinal diseases, in contrast with a raised risk among CF patients.
Conclusion:
Heterozygosity for CF gene mutations does not protect against gastrointestinal diseases where impaired barrier function may be relevant.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Genome Copying Errors
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

